1. Home
  2. KALU vs OGN Comparison

KALU vs OGN Comparison

Compare KALU & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaiser Aluminum Corporation

KALU

Kaiser Aluminum Corporation

HOLD

Current Price

$130.72

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.11

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALU
OGN
Founded
1946
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
KALU
OGN
Price
$130.72
$6.11
Analyst Decision
Buy
Hold
Analyst Count
3
4
Target Price
$107.00
$11.75
AVG Volume (30 Days)
166.3K
3.0M
Earning Date
04-22-2026
04-30-2026
Dividend Yield
2.56%
1.34%
EPS Growth
135.89
N/A
EPS
6.77
0.72
Revenue
$1,585,900,000.00
$6,216,000,000.00
Revenue This Year
$13.37
$0.42
Revenue Next Year
$2.62
$1.67
P/E Ratio
$17.83
$8.31
Revenue Growth
N/A
N/A
52 Week Low
$46.81
$5.69
52 Week High
$150.00
$14.70

Technical Indicators

Market Signals
Indicator
KALU
OGN
Relative Strength Index (RSI) 59.99 39.63
Support Level $116.89 N/A
Resistance Level $136.10 $7.87
Average True Range (ATR) 5.10 0.24
MACD 1.43 0.03
Stochastic Oscillator 99.08 51.79

Price Performance

Historical Comparison
KALU
OGN

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: